Contact
About Us
Products & Technology
LungFit PH
Pipeline
News & Events
Press Releases
Presentations & Publications
Events
Investors
Stock Data
SEC Filings
Governance
Careers
Contact
Press Releases
Stay
Notified
This is a search field with an auto-suggest feature attached.
Search
There are no suggestions because the search field is empty.
Beyond Air® Announces Positive Data from At-Home Pilot Study in Patients with Refractory NTM Lung Infection Treated with (NO) using the LungFit® GO at the CHEST Annual Meeting 2022
October 17, 2022
Beyond Cancer™ to Present Pre-Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2022 SITC Annual Meeting
October 5, 2022
Beyond Air® Announces that Annals of the American Thoracic Society Published a Review of the Third Pilot Study of High Dose Nitric Oxide for Bronchiolitis
October 3, 2022
Beyond Air® To Participate in Three Upcoming Investor Conferences
September 16, 2022
Beyond Air® Affiliate Beyond Cancer™ Doses Initial Patient in First-in-Human Phase 1 Study of Ultra-High Concentration Nitric Oxide Therapy at Tel Aviv Sourasky Medical Center (Ichilov)
August 23, 2022
Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2023
August 11, 2022
Beyond Air® Schedules First Fiscal Quarter 2023 Financial Results Conference Call and Webcast
July 27, 2022
Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022
June 28, 2022
Beyond Air’s LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure
June 28, 2022
Beyond Air® Announces Fiscal Year End 2022 Financial Results Conference Call and Webcast Moved to Tuesday, June 28th
June 14, 2022
Previous
1
…
6
7
8
9
10
…
17
Next
Sign up for updates from Beyond Air, Inc.
